Investigation by Parkinson’s Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson’s disease: further results of randomised trial and confidential inquiry

Objective: To determine whether the excess mortality observed in patients who received both levodopa and selegiline in a randomised trial could be explained by revised diagnosis of Parkinson’s disease, autonomic or cardiovascular effects, more rapid disease progression, or drug interactions. Design:...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ben-Shlomo, Y, Churchyard, A, Head, J, Hurwitz, B, Overstall, P, Ockelford, J, Lees, A J
Natura: Artigo
Lingua:Inglês
Pubblicazione: British Medical Journal 1998
Soggetti:
Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC28519/
https://ncbi.nlm.nih.gov/pubmed/9583926
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi